✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Kimia Biosciences Ltd.

KIMIABL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹153 Cr.
P/E
15.88

Kimia Biosciences Ltd.

  • Kimia Biosciences
  • Krebs Biochem.&Inds
  • Achyut Healthcare

FAQs on Kimia Biosciences Ltd. Shareprice

Kimia Biosciences has given lower returns compared to its competitors.
Kimia Biosciences has grown at ~-8.91% over the last 3yrs while peers have grown at a median rate of -1.02%

Kimia Biosciences is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Kimia Biosciences is 14.51, while 3 year average PE is 13.42.
Also latest EV/EBITDA of Kimia Biosciences is 12.97 while 3yr average is 1155.

View FAQ's On Business

Growth Table

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Achyut Healthcare

Balance Sheet

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Achyut Healthcare

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Achyut Healthcare

Cash Flow

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Achyut Healthcare

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Achyut Healthcare

Quarterly Results

  • Kimia Biosciences Ltd.
  • Krebs Biochem.&Inds
  • Achyut Healthcare

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Kimia Biosciences Ltd. Financials

Balance sheet of Kimia Biosciences is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Kimia Biosciences is increasing.
Latest net debt of Kimia Biosciences is ₹35 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹31.41 Crs.

The profit is oscillating.
The profit of Kimia Biosciences is ₹7.8 Crs for TTM, ₹9.61 Crs for Mar 2025 and -₹5.31 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kimia Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech